Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death
about
sameAs
Inflammation and infection do not promote arterial aging and cardiovascular disease risk factors among lean horticulturalistsAssociation between blood lead and walking speed in the National Health and Nutrition Examination Survey (NHANES 1999-2002)Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveSaturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidenceTrans fatty acids: effects on cardiometabolic health and implications for policyElevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjectsLong QT Syndrome: An Emerging Role for Inflammation and ImmunityHistone Deacetylases and Cardiometabolic DiseasesCardiac autonomic testing and diagnosing heart disease. "A clinical perspective"Obstructive sleep apnea syndrome and cardiovascular disease: The influence of C-reactive proteinRole of C-reactive protein in cardiovascular diseaseMortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989-2001Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemiaInduction of glycosylation in human C-reactive protein under different pathological conditions.C-reactive protein levels in the brugada syndrome.Plasma biomarkers for prediction of sudden cardiac death: another piece of the risk stratification puzzle?Association of baseline, longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients.Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran communityHigh-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneLaboratory evaluation of a new lateral-flow-based point-of-care rapid test for assessment of chronic systemic inflammation.Novel markers of peripheral arterial disease.Is the association between optimistic cardiovascular risk perceptions and lower rates of cardiovascular disease mortality explained by biomarkers of systemic inflammation or endothelial function? A case-cohort study.Retinal emboli and cardiovascular disease: the Beaver Dam Eye Study.Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort.Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden.Why do young people with chronic kidney disease die early?Tools for risk stratification of sudden cardiac death: a review of the literature in different patient populationsEarly identification of risk factors for sudden cardiac death.Risk of mortality (including sudden cardiac death) and major cardiovascular events in atypical and typical antipsychotic users: a study with the general practice research database.Vulnerable plaque: the pathology of unstable coronary lesions.Synergism between arrhythmia and hyperhomo-cysteinemia in structural heart disease.Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).Whole grains protect against atherosclerotic cardiovascular disease.C-reactive protein in adolescent twins: patterns and relationship to adiposity.Hormonal and nutritional effects on cardiovascular risk markers in young women.Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.The level of hs-CRP in coronary artery ectasia and its response to statin and angiotensin-converting enzyme inhibitor treatment.Sudden cardiac death risk stratification.Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapiesBiomarkers in electrophysiology: role in arrhythmias and resynchronization therapy.
P2860
Q21562377-C9FE0747-6A00-4B3E-8842-C0B9F0F5FD05Q23915301-78B798C3-A6A2-49C8-ACB5-1B06A848A95EQ24594814-B38C42C0-813E-42B8-A8AF-0FDC8B572764Q24634414-572CAAB1-A06D-453D-9FFE-F1BEB7628CC2Q24654965-9478D0C1-E797-433B-B0AE-4C294259D2A3Q24791309-CC931F25-63C8-40B3-BED7-B503F4D6EE9FQ26769710-5F528D56-60BE-46C4-BD57-8483C9C13B8BQ26800062-779427A5-10AD-49BC-9C4E-AD6C6D502AB9Q26998895-B5124EE7-A923-4CC4-8D6B-DA54F39A1250Q27003309-323DDD4B-9074-453D-8CF1-5E36EC543F0CQ28166927-5DB2BA5F-4428-4480-8985-C5FA4830A38DQ28469059-97DC6EB8-8820-405B-82AC-9ABFC96CF0E1Q28744457-5496D364-9793-4166-99FE-E495C7817EFFQ30725042-EC0AB3F7-7053-4AB4-8E92-FA21739B67BFQ33160813-27E94EB1-FE85-41B8-9514-58E067E02A74Q33353044-36B7C9EF-49F4-4D77-957E-6CEC601481DFQ33869113-8A92B356-D98B-42D9-8EB5-AF5701E7694BQ33906348-AF0A3B16-2ED1-4202-A97D-9534D03C39A3Q33979763-C3E61807-9353-4311-B4CE-DCE8EF96AEC2Q33979779-7C232B1C-602A-4138-B3B1-B9FC49E5C31BQ33984026-24B6FD1B-EA32-49C2-BE3B-79D52F974E70Q34174057-EAA3B38A-4BC0-4D2E-A5F5-13578EA24D5FQ34331042-EDCD3C9C-85F4-4340-B27A-605A43BC958BQ34374943-C76D52EA-90B2-4C8F-80E0-AAAACFBDF7AAQ34375590-FC988710-252E-4DF3-9838-07E85DCD96ECQ34453230-547BD5DC-04FE-4EEC-9B5F-4A5BAF47AC01Q34541818-10D1E152-3685-4DB0-960E-8235D3A01B5AQ34640857-5AD8EFBD-11D8-4472-95CF-EB99D1BE1DFAQ34659165-BE36F344-3717-4288-9EEF-3E616F31FCCEQ35022876-E268098F-C0A9-41D0-B4AD-2B64AF9D0C9DQ35098436-4514A319-9B39-447F-81BB-44C7E10FBBA4Q35107904-AC5C4A0C-C643-47AF-AE39-05808924EB33Q35124783-60C78B4D-2F60-457A-A6B5-6AC6BE9415D8Q35432699-5CBB0056-F4A3-44A1-88CE-97EEF4552BACQ35536136-1094588A-5356-4BF2-B7F3-B61B5B8DA5E1Q35581688-524642DE-1968-4471-AB27-CED2877332C7Q35649241-C0123622-1619-4117-9624-FA60D9705DDCQ35738748-AFB5F8A2-13F0-4AE6-A28E-B90304E3EEBDQ35771323-BE92336B-5EF8-41B1-A370-D95CD9F61CC5Q35805412-31E504CB-8D3F-480F-BFF2-AB35E4E941FC
P2860
Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Prospective study of C-reactiv ...... ictors of sudden cardiac death
@ast
Prospective study of C-reactiv ...... ictors of sudden cardiac death
@en
Prospective study of C-reactiv ...... ictors of sudden cardiac death
@nl
type
label
Prospective study of C-reactiv ...... ictors of sudden cardiac death
@ast
Prospective study of C-reactiv ...... ictors of sudden cardiac death
@en
Prospective study of C-reactiv ...... ictors of sudden cardiac death
@nl
prefLabel
Prospective study of C-reactiv ...... ictors of sudden cardiac death
@ast
Prospective study of C-reactiv ...... ictors of sudden cardiac death
@en
Prospective study of C-reactiv ...... ictors of sudden cardiac death
@nl
P2093
P3181
P1433
P1476
Prospective study of C-reactiv ...... ictors of sudden cardiac death
@en
P2093
Christine M Albert
Paul M Ridker
P304
P3181
P356
10.1161/01.CIR.0000017493.03108.1C
P407
P577
2002-06-04T00:00:00Z